Abstract
Following a peripheral nerve injury (PNI), neurons have the capacity to regenerate but the rate is remarkably slow. Microsurgical treatments are used to reconnect the nerve stumps following a PNI and encourage the regeneration of axons; however, there are currently no therapies available to promote the rate of this regeneration. Drug therapies available for PNI tend to focus on the resulting symptoms such as neuropathic pain, inflammation, and weakness without modifying the condition itself. Effectively designed pharmacological treatments could potentially increase the regenerative rate as well as maintain neuronal viability and improve axonal specificity to target organs. Appropriate drug agents need to target specific events following a nerve injury and advancements in understanding of the molecular and cellular cascades which follow injury could inform this. Some drugs and targets within signaling pathways have been identified, but challenges remain with clinical translation.
References
Ahmed I, Liu HY, Mamiya PC, Ponery AS, Babu AN, Weik T, Schindler M, Meiners S (2006) Three-dimensional nanofibrillar surfaces covalently modified with tenascin-C-derived peptides enhance neuronal growth in vitro. J Biomed Mater Res A 76:851–860
Allodi I, Udina E, Navarro X (2012) Specificity of peripheral nerve regeneration: interactions at the axon level. Prog Neurobiol 98:16–37
Angius D, Wang H, Spinner RJ, Gutierrez-Cotto Y, Yaszemski MJ, Windebank AJ (2012) A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffolds. Biomaterials 33:8034–8039
Azizi S, Mohammadi R, Amini K, Fallah R (2012) Effects of topically administered FK506 on sciatic nerve regeneration and reinnervation after vein graft repair of short nerve gaps. Neurosurg Focus 32:E5
Baker R (2006) Gait analysis methods in rehabilitation. J Neuroeng Rehabil 3:4
Baldwin SP, Krewson CE, Saltzman WM (1996) PC12 cell aggregation and neurite growth in gels of collagen, laminin and fibronectin. Int J Dev Neurosci 14:351–364
Barhwal K, Hota SK, Prasad D, Singh SB, Ilavazhagan G (2008) Hypoxia-induced deactivation of NGF-mediated ERK1/2 signaling in hippocampal cells: neuroprotection by acetyl-L-carnitine. J Neurosci Res 86:2705–2721
Benedetti MG, Beghi E, De Tanti A, Cappozzo A, Basaglia N, Cutti AG, Cereatti A, Stagni R, Verdini F, Manca M, Fantozzi S, Mazza C, Camomilla V, Campanini I, Castagna A, Cavazzuti L, Del Maestro M, Croce UD, Gasperi M, Leo T, Marchi P, Petrarca M, Piccinini L, Rabuffetti M, Ravaschio A, Sawacha Z, Spolaor F, Tesio L, Vannozzi G, Visintin I, Ferrarin M (2017) SIAMOC position paper on gait analysis in clinical practice: general requirements, methods and appropriateness. Results of an Italian consensus conference. Gait Posture 58:252–260
Benito C, Davis CM, Gomez-Sanchez JA, Turmaine M, Meijer D, Poli V, Mirsky R, Jessen KR (2017) STAT3 controls the long-term survival and phenotype of repair Schwann cells during nerve regeneration. J Neurosci 37:4255–4269
Bhangra KS, Busuttil F, Phillips JB, Rahim AA (2016) Using stem cells to grow artificial tissue for peripheral nerve repair. Stem Cells Int 2016:7502178
Boerma M, Fu Q, Wang J, Loose DS, Bartolozzi A, Ellis JL, Mcgonigle S, Paradise E, Sweetnam P, Fink LM, Vozenin-Brotons MC, Hauer-Jensen M (2008) Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin. Blood Coagul Fibrinolysis 19:709–718
Bota O, Fodor L (2019) The influence of drugs on peripheral nerve regeneration. Drug Metab Rev 51:1–27
Bozkurt A, Brook GA, Moellers S, Lassner F, Sellhaus B, Weis J, Woeltje M, Tank J, Beckmann C, Fuchs P, Damink LO, Schugner F, Heschel I, Pallua N (2007) In vitro assessment of axonal growth using dorsal root ganglia explants in a novel three-dimensional collagen matrix. Tissue Eng 13:2971–2979
Brannon-Peppas L (1997) Polymers in controlled drug delivery. MD+DI Qmed. Medical Plastics and Biomaterials Magazine, Santa Monica, California
Breyer MD, Look AT, Cifra A (2015) From bench to patient: model systems in drug discovery. Dis Model Mech 8:1171–1174
Burnett MG, Zager EL (2004) Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus 16:E1
Busuttil F, Rahim AA, Phillips JB (2017) Combining gene and stem cell therapy for peripheral nerve tissue engineering. Stem Cells Dev 26:231–238
Chan KM, Gordon T, Zochodne DW, Power HA (2014) Improving peripheral nerve regeneration: from molecular mechanisms to potential therapeutic targets. Exp Neurol 261:826–835
Chen ZL, Yu WM, Strickland S (2007) Peripheral regeneration. Annu Rev Neurosci 30:209–233
Chen P, Piao X, Bonaldo P (2015) Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury. Acta Neuropathol 130:605–618
Cheng C, Webber CA, Wang J, Xu Y, Martinez JA, Liu WQ, Mcdonald D, Guo GF, Nguyen MD, Zochodne DW (2008) Activated RHOA and peripheral axon regeneration. Exp Neurol 212:358–369
Chiang MC, Cheng YC, Chen HM, Liang YJ, Yen CH (2014) Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway. Mitochondrion 14:7–17
Clinicaltrials.gov (2019a) 4-aminopyridine treatment for nerve injury [Online]. U.S. National Library of Medicine. https://ClinicalTrials.gov/show/NCT03701581. Accessed 2019
Clinicaltrials.gov (2019b) Tesamorelin to improve functional outcomes after peripheral nerve injury [Online]. U.S. National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT03150511?cond=nerve+injury&draw=3&rank=4. Accessed 2019
Demidenko ZN, Blagosklonny MV (2009) At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence. Cell Cycle 8:1901–1904
Denayer T, Stohr T, Roy MV (2014) Animal models in translational medicine: validation and prediction. New Horiz Transl Med 2:5–11
Deumens R, Bozkurt A, Meek MF, Marcus MA, Joosten EA, Weis J, Brook GA (2010) Repairing injured peripheral nerves: bridging the gap. Prog Neurobiol 92:245–276
Donaldson K, Hoke A (2014) Studying axonal degeneration and regeneration using in vitro and in vivo model: the translational potential. Future Neurol 9:461–473
Dubovy P, Jancalek R, Kubek T (2013) Role of inflammation and cytokines in peripheral nerve regeneration. Int Rev Neurobiol 108:173–206
Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661–665
Dunn J, Blight A (2011) Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis. Curr Med Res Opin 27:1415–1423
Elbaz AA, Abu-Almaaty AH, Hassan MK, Mohammed EA, Aziz MM (2017) Therapeutic role of Schwann cells and resveratrol or melatonin combination in peripheral nerve injured rat models. J Exp Appl Animal Sci 2:190–210
Elfar JC, Jacobson JA, Puzas JE, Rosier RN, Zuscik MJ (2008) Erythropoietin accelerates functional recovery after peripheral nerve injury. J Bone Joint Surg Am 90:1644–1653
Eto M, Sumi H, Fujimura H, Yoshikawa H, Sakoda S (2008) Pioglitazone promotes peripheral nerve remyelination after crush injury through CD36 upregulation. J Peripher Nerv Syst 13:242–248
Fansa H, Keilhoff G, Altmann S, Plogmeier K, Wolf G, Schneider W (1999) The effect of the immunosuppressant FK 506 on peripheral nerve regeneration following nerve grafting. J Hand Surg (Br) 24:38–42
Faroni A, Mobasseri SA, Kingham PJ, Reid AJ (2015) Peripheral nerve regeneration: experimental strategies and future perspectives. Adv Drug Deliv Rev 82–83:160–167
Federici T, Liu JK, Teng Q, Yang J, Boulis NM (2007) A means for targeting therapeutics to peripheral nervous system neurons with axonal damage. Neurosurgery 60:911–918; discussion 911–8
Fex Svennigsen A, Dahlin LB (2013) Repair of the peripheral nerve-remyelination that works. Brain Sci 3:1182–1197
Fu SY, Gordon T (1995) Contributing factors to poor functional recovery after delayed nerve repair: prolonged axotomy. J Neurosci 15:3876–3885
Fu Y, Kao WJ (2010) Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 7:429–444
Fuentes EO, Leemhuis J, Stark GB, Lang EM (2008) Rho kinase inhibitors Y27632 and H1152 augment neurite extension in the presence of cultured Schwann cells. J Brachial Plex Peripher Nerve Inj 3:19
Gaudet AD, Popovich PG, Ramer MS (2011) Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation 8:110
Geuna S, Raimondo S, Fregnan F, Haastert-Talini K, Grothe C (2016) In vitro models for peripheral nerve regeneration. Eur J Neurosci 43:287–296
Gingras M, Bergeron J, Dery J, Durham HD, Berthod F (2003) In vitro development of a tissue-engineered model of peripheral nerve regeneration to study neurite growth. FASEB J 17:2124–2126
Gold BG, Zhong YP (2004) FK506 requires stimulation of the extracellular signal-regulated kinase 1/2 and the steroid receptor chaperone protein p23 for neurite elongation. Neurosignals 13:122–129
Gold BG, Storm-Dickerson T, Austin DR (1994) The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor Neurol Neurosci 6:287–296
Gold BG, Katoh K, Storm-Dickerson T (1995) The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci 15:7509–7516
Gold BG, Densmore V, Shou W, Matzuk MM, Gordon HS (1999) Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther 289:1202–1210
Gomez-Sanchez JA, Carty L, Iruarrizaga-Lejarreta M, Palomo-Irigoyen M, Varela-Rey M, Griffith M, Hantke J, Macias-Camara N, Azkargorta M, Aurrekoetxea I, De Juan VG, Jefferies HB, Aspichueta P, Elortza F, Aransay AM, Martinez-Chantar ML, Baas F, Mato JM, Mirsky R, Woodhoo A, Jessen KR (2015) Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol 210:153–168
Greek R (2012) Animal models in drug development. IntechOpen, London
Grisk O, Schluter T, Reimer N, Zimmermann U, Katsari E, Plettenburg O, Lohn M, Wollert HG, Rettig R (2012) The Rho kinase inhibitor SAR407899 potently inhibits endothelin-1-induced constriction of renal resistance arteries. J Hypertens 30:980–989
Hall SM (1986) Regeneration in cellular and acellular autografts in the peripheral nervous system. Neuropathol Appl Neurobiol 12:27–46
Hall S (2005) The response to injury in the peripheral nervous system. J Bone Joint Surg Br 87:1309–1319
Hart AM, Wiberg M, Youle M, Terenghi G (2002) Systemic acetyl-L-carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma. Exp Brain Res 145:182–189
Hart AM, Terenghi G, Kellerth JO, Wiberg M (2004) Sensory neuroprotection, mitochondrial preservation, and therapeutic potential of N-acetyl-cysteine after nerve injury. Neuroscience 125:91–101
Hart AM, Terenghi G, Wiberg M (2008) Neuronal death after peripheral nerve injury and experimental strategies for neuroprotection. Neurol Res 30:999–1011
Herbert CB, Nagaswami C, Bittner GD, Hubbell JA, Weisel JW (1998) Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. J Biomed Mater Res 40:551–559
Hiraga A, Kuwabara S, Doya H, Kanai K, Fujitani M, Taniguchi J, Arai K, Mori M, Hattori T, Yamashita T (2006) Rho-kinase inhibition enhances axonal regeneration after peripheral nerve injury. J Peripher Nerv Syst 11:217–224
Hoke A, Brushart T (2010) Introduction to special issue: challenges and opportunities for regeneration in the peripheral nervous system. Exp Neurol 223:1–4
Hoke A, Keswani SC (2005) Neuroprotection in the PNS: erythropoietin and immunophilin ligands. Ann N Y Acad Sci 1053:491–501
Hopkins AM, Desimone E, Chwalek K, Kaplan DL (2015) 3D in vitro modeling of the central nervous system. Prog Neurobiol 125:1–25
Isaacs J (2013) Major peripheral nerve injuries. Hand Clin 29:371–382
Jessen KR, Mirsky R (2016) The repair Schwann cell and its function in regenerating nerves. J Physiol 594:3521–3531
Jessen KR, Mirsky R, Salzer J (2008) Introduction. Schwann cell biology. Glia 56:1479–1480
Jin E, Sano M (2008) Neurite outgrowth of NG108-15 cells induced by heat shock protein 90 inhibitors. Cell Biochem Funct 26:825–832
Jones KJ, Kinderman NB, Oblinger MM (1997) Alterations in glial fibrillary acidic protein (GFAP) mRNA levels in the hamster facial motor nucleus: effects of axotomy and testosterone. Neurochem Res 22:1359–1366
Jones S, Eisenberg HM, Jia X (2016) Advances and future applications of augmented peripheral nerve regeneration. Int J Mol Sci 17
Joshi AR, Bobylev I, Zhang G, Sheikh KA, Lehmann HC (2015) Inhibition of Rho-kinase differentially affects axon regeneration of peripheral motor and sensory nerves. Exp Neurol 263:28–38
Jost SC, Doolabh VB, Mackinnon SE, Lee M, Hunter D (2000) Acceleration of peripheral nerve regeneration following FK506 administration. Restor Neurol Neurosci 17:39–44
Karsidag S, Akcal A, Sahin S, Karsidag S, Kabukcuoglu F, Ugurlu K (2012) Neurophysiological and morphological responses to treatment with acetyl-L-carnitine in a sciatic nerve injury model: preliminary data. J Hand Surg Eur Vol 37:529–536
Klesse LJ, Meyers KA, Marshall CJ, Parada LF (1999) Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells. Oncogene 18:2055–2068
Knott EP, Assi M, Pearse DD (2014) Cyclic AMP signaling: a molecular determinant of peripheral nerve regeneration. Biomed Res Int 2014:651625
Ko KR, Frampton JP (2016) Developments in 3D neural cell culture models: the future of neurotherapeutics testing? Expert Rev Neurother 16:739–741
Kofron CM, Fong VJ, Hoffman-Kim D (2009) Neurite outgrowth at the interface of 2D and 3D growth environments. J Neural Eng 6:016002
Kokkalis ZT, Soucacos PN, Terzis JK (2009) Effect of acetyl-L-carnitine on axonal sprouting following donor nerve injury distal to an end-to-side neurorrhaphy model. J Reconstr Microsurg 25:483–495
Kostopoulos VK, Davis CL, Terzis JK (2009) Effects of acetylo-L-carnitine in end-to-side neurorrhaphy: a pilot study. Microsurgery 29:456–463
Kraus D, Boyle V, Leibig N, Stark GB, Penna V (2015) The neuro-spheroid – a novel 3D in vitro model for peripheral nerve regeneration. J Neurosci Methods 246:97–105
Krekoski CA, Neubauer D, Zuo J, Muir D (2001) Axonal regeneration into acellular nerve grafts is enhanced by degradation of chondroitin sulfate proteoglycan. J Neurosci 21:6206–6213
Kuffler DP (2014) An assessment of current techniques for inducing axon regeneration and neurological recovery following peripheral nerve trauma. Prog Neurobiol 116:1–12
Kujawa KA, Kinderman NB, Jones KJ (1989) Testosterone-induced acceleration of recovery from facial paralysis following crush axotomy of the facial nerve in male hamsters. Exp Neurol 105:80–85
Labroo P, Ho S, Sant H, Shea J, Gale BK, Agarwal J (2016) Controlled delivery of FK506 to improve nerve regeneration. Shock 46:154–159
Labroo P, Shea J, Sant H, Gale B, Agarwal J (2017) Effect of combining FK506 and neurotrophins on neurite branching and elongation. Muscle Nerve 55:570–581
Lee M, Doolabh VB, Mackinnon SE, Jost S (2000) FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve 23:633–640
Lezana JP, Dagan SY, Robinson A, Goldstein RS, Fainzilber M, Bronfman FC, Bronfman M (2016) Axonal PPARgamma promotes neuronal regeneration after injury. Dev Neurobiol 76:688–701
Lie M, Grover M, Whitlon DS (2010) Accelerated neurite growth from spiral ganglion neurons exposed to the Rho kinase inhibitor H-1152. Neuroscience 169:855–862
Liechty WB, Kryscio DR, Slaughter BV, Peppas NA (2010) Polymers for drug delivery systems. Annu Rev Chem Biomol Eng 1:149–173
Lingor P, Teusch N, Schwarz K, Mueller R, Mack H, Bahr M, Mueller BK (2007) Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J Neurochem 103:181–189
Ma TC, Willis DE (2015) What makes a RAG regeneration associated? Front Mol Neurosci 8:43
Madura T, Yamashita T, Kubo T, Fujitani M, Hosokawa K, Tohyama M (2004) Activation of Rho in the injured axons following spinal cord injury. EMBO Rep 5:412–417
Madura T, Kubo T, Tanag M, Matsuda K, Tomita K, Yano K, Hosokawa K (2007) The Rho-associated kinase inhibitor fasudil hydrochloride enhances neural regeneration after axotomy in the peripheral nervous system. Plast Reconstr Surg 119:526–535
Madura T, Tomita K, Terenghi G (2011) Ibuprofen improves functional outcome after axotomy and immediate repair in the peripheral nervous system. J Plast Reconstr Aesthet Surg 64:1641–1646
Manaenko A, Fathali N, Chen H, Suzuki H, Williams S, Zhang JH, Tang J (2010) Heat shock protein 70 upregulation by geldanamycin reduces brain injury in a mouse model of intracerebral hemorrhage. Neurochem Int 57:844–850
Marin J, Blanco T, Marin JJ, Moreno A, Martitegui E, Aragues JC (2019) Integrating a gait analysis test in hospital rehabilitation: a service design approach. PLoS One 14:e0224409
Martin G, Duez H, Blanquart C, Berezowski V, Poulain P, Fruchart JC, Najib-Fruchart J, Glineur C, Staels B (2001) Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I. J Clin Invest 107:1423–1432
Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6:13
Matos L, Gouveia AM, Almeida H (2017) Resveratrol attenuates copper-induced senescence by improving cellular proteostasis. Oxidative Med Cell Longev 2017:3793817
Mattsson P, Janson AM, Aldskogius H, Svensson M (2001) Nimodipine promotes regeneration and functional recovery after intracranial facial nerve crush. J Comp Neurol 437:106–117
Mattsson P, Frostell A, Bjorck G, Persson JKE, Hakim R, Zedenius J, Svensson M (2018) Recovery of voice after reconstruction of the recurrent laryngeal nerve and adjuvant nimodipine. World J Surg 42:632–638
Mekaj AY, Morina AA, Bytyqi CI, Mekaj YH, Duci SB (2014) Application of topical pharmacological agents at the site of peripheral nerve injury and methods used for evaluating the success of the regenerative process. J Orthop Surg Res 9:94
Mohammadi R, Hirsaee MA, Amini K (2013) Improvement of functional recovery of transected peripheral nerve by means of artery grafts filled with diclofenac. Int J Surg 11:259–264
Mokarram N, Merchant A, Mukhatyar V, Patel G, Bellamkonda RV (2012) Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials 33:8793–8801
Moschou M, Kosmidis EK, Kaloyianni M, Geronikaki A, Dabarakis N, Theophilidis G (2008) In vitro assessment of the neurotoxic and neuroprotective effects of N-acetyl-L-cysteine (NAC) on the rat sciatic nerve fibers. Toxicol In Vitro 22:267–274
Mueller BK, Mack H, Teusch N (2005) Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 4:387–398
Mulder T, Nienhuis B, Pauwels J (1998) Clinical gait analysis in a rehabilitation context: some controversial issues. Clin Rehabil 12:99–106
Navarro X (2016) Functional evaluation of peripheral nerve regeneration and target reinnervation in animal models: a critical overview. Eur J Neurosci 43:271–286
Nishio Y, Koda M, Kitajo K, Seto M, Hata K, Taniguchi J, Moriya H, Fujitani M, Kubo T, Yamashita T (2006) Delayed treatment with Rho-kinase inhibitor does not enhance axonal regeneration or functional recovery after spinal cord injury in rats. Exp Neurol 200:392–397
Nunez G, Del Peso L (1998) Linking extracellular survival signals and the apoptotic machinery. Curr Opin Neurobiol 8:613–618
Olson MF (2008) Applications for ROCK kinase inhibition. Curr Opin Cell Biol 20:242–248
Padhy BM, Gupta YK (2011) Drug repositioning: re-investigating existing drugs for new therapeutic indications. J Postgrad Med 57:153–160
Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D, Fujise K, Liu M (2009) Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res 69:518–525
Pearse DD, Pereira FC, Marcillo AE, Bates ML, Berrocal YA, Filbin MT, Bunge MB (2004) cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 10:610–616
Phan DQ, Schuind F (2012) Tolerance and effects of FK506 (tacrolimus) on nerve regeneration: a pilot study. J Hand Surg Eur Vol 37:537–543
Pillai O, Panchagnula R (2001) Polymers in drug delivery. Curr Opin Chem Biol 5:447–451
Pittier R, Sauthier F, Hubbell JA, Hall H (2005) Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices. J Neurobiol 63:1–14
Poppler LH, Ee X, Schellhardt L, Hoben GM, Pan D, Hunter DA, Yan Y, Moore AM, Snyder-Warwick AK, Stewart SA, Mackinnon SE, Wood MD (2016) Axonal growth arrests after an increased accumulation of Schwann cells expressing senescence markers and stromal cells in acellular nerve allografts. Tissue Eng Part A 22:949–961
Puhl AC, Milton FA, Cvoro A, Sieglaff DH, Campos JC, Bernardes A, Filgueira CS, Lindemann JL, Deng T, Neves FA, Polikarpov I, Webb P (2015) Mechanisms of peroxisome proliferator activated receptor gamma regulation by non-steroidal anti-inflammatory drugs. Nucl Recept Signal 13:e004
Quick TJ, Singh AK, Fox M, Sinisi M, Macquillan A (2016) A quantitative assessment of the functional recovery of flexion of the elbow after nerve transfer in patients with a brachial plexus injury. Bone Joint J 98-B:1517–1520
Quintanilla RA, Utreras E, Cabezas-Opazo FA (2014) Role of PPAR gamma in the differentiation and function of neurons. PPAR Res 2014:768594
Raff MC, Hornby-Smith A, Brockes JP (1978) Cyclic AMP as a mitogenic signal for cultured rat Schwann cells. Nature 273:672–673
Rayner M, Laranjeira S, Evans R, Shipley R, Healy J, Phillips J (2018) Developing an in vitro model to screen drugs for nerve regeneration. Anat Rec 301:1628–1637
Rayner M, Brown H, Wilcox M, Phillips J, Quick T (2019) Quantifying regeneration in patients following peripheral nerve injury. J Plast Reconstr Aesthet Surg 73:201–208
Reid AJ, Shawcross SG, Hamilton AE, Wiberg M, Terenghi G (2009) N-acetylcysteine alters apoptotic gene expression in axotomised primary sensory afferent subpopulations. Neurosci Res 65:148–155
Roloff F, Scheiblich H, Dewitz C, Dempewolf S, Stern M, Bicker G (2015) Enhanced neurite outgrowth of human model (NT2) neurons by small-molecule inhibitors of Rho/ROCK signaling. PLoS One 10:e0118536
Rustemeyer J, Van De Wal R, Keipert C, Dicke U (2010) Administration of low-dose FK 506 accelerates histomorphometric regeneration and functional outcomes after allograft nerve repair in a rat model. J Craniomaxillofac Surg 38:134–140
Saheb-Al-Zamani M, Yan Y, Farber SJ, Hunter DA, Newton P, Wood MD, Stewart SA, Johnson PJ, Mackinnon SE (2013) Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence. Exp Neurol 247:165–177
Scheller K, Scheller C (2012) Nimodipine promotes regeneration of peripheral facial nerve function after traumatic injury following maxillofacial surgery: an off label pilot-study. J Cranio-Maxillofac Surg 40:427–434
Schmandke A, Schmandke A, Strittmatter SM (2007) ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist 13:454–469
Schmitt AB, Breuer S, Liman J, Buss A, Schlangen C, Pech K, Hol EM, Brook GA, Noth J, Schwaiger FW (2003) Identification of regeneration-associated genes after central and peripheral nerve injury in the adult rat. BMC Neurosci 4:8
Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, Mcdonald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG, Inflammation & Host Response to Injury, L. S. C. R. P (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110:3507–3512
Sharma N, Coughlin L, Porter RG, Tanzer L, Wurster RD, Marzo SJ, Jones KJ, Foecking EM (2009) Effects of electrical stimulation and gonadal steroids on rat facial nerve regenerative properties. Restor Neurol Neurosci 27:633–644
Stefani M, Markus MA, Lin RC, Pinese M, Dawes IW, Morris BJ (2007) The effect of resveratrol on a cell model of human aging. Ann N Y Acad Sci 1114:407–418
Stewart HJ, Eccleston PA, Jessen KR, Mirsky R (1991) Interaction between cAMP elevation, identified growth factors, and serum components in regulating Schwann cell growth. J Neurosci Res 30:346–352
Subramanian A, Krishnan UM, Sethuraman S (2009) Development of biomaterial scaffold for nerve tissue engineering: biomaterial mediated neural regeneration. J Biomed Sci 16:108
Suckling K (2008) Animal research: too much faith in models clouds judgement. Nature 455:460
Sulaiman OA, Voda J, Gold BG, Gordon T (2002) Fk506 increases peripheral nerve regeneration after chronic axotomy but not after chronic schwann cell denervation. Exp Neurol 175:127–137
Sun HH, Saheb-Al-Zamani M, Yan Y, Hunter DA, Mackinnon SE, Johnson PJ (2012) Geldanamycin accelerated peripheral nerve regeneration in comparison to FK-506 in vivo. Neuroscience 223:114–123
Sundem L, Chris Tseng KC, Li H, Ketz J, Noble M, Elfar J (2016) Erythropoietin enhanced recovery after traumatic nerve injury: myelination and localized effects. J Hand Surg Am 41:999–1010
Tajdaran K, Shoichet MS, Gordon T, Borschel GH (2015) A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). Biotechnol Bioeng 112:1948–1953
Tajdaran K, Chan K, Shoichet MS, Gordon T, Borschel GH (2019) Local delivery of FK506 to injured peripheral nerve enhances axon regeneration after surgical nerve repair in rats. Acta Biomater 96:211–221
Tang BL (2003) Inhibitors of neuronal regeneration: mediators and signaling mechanisms. Neurochem Int 42:189–203
Tang YD, Zheng XS, Ying TT, Yuan Y, Li ST (2015) Nimodipine-mediated re-myelination after facial nerve crush injury in rats. J Clin Neurosci 22:1661–1668
Tedeschi A (2011) Tuning the orchestra: transcriptional pathways controlling axon regeneration. Front Mol Neurosci 4:60
Tetzlaff J, Tanzer L, Jones KJ (2007) Exogenous androgen treatment delays the stress response following hamster facial nerve injury. J Neuroendocrinol 19:383–389
Tos P, Ronchi G, Papalia I, Sallen V, Legagneux J, Geuna S, Giacobini-Robecchi MG (2009) Chapter 4: methods and protocols in peripheral nerve regeneration experimental research: part I-experimental models. Int Rev Neurobiol 87:47–79
Tseng KC, Li H, Clark A, Sundem L, Zuscik M, Noble M, Elfar J (2016) 4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury. EMBO Mol Med 8:1409–1420
Udina E, Ladak A, Furey M, Brushart T, Tyreman N, Gordon T (2010) Rolipram-induced elevation of cAMP or chondroitinase ABC breakdown of inhibitory proteoglycans in the extracellular matrix promotes peripheral nerve regeneration. Exp Neurol 223:143–152
Van De Velde S, Van Bergen T, Sijnave D, Hollanders K, Castermans K, Defert O, Leysen D, Vandewalle E, Moons L, Stalmans I (2014) AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia. Invest Ophthalmol Vis Sci 55:1006–1016
Varejao AS, Cabrita AM, Meek MF, Bulas-Cruz J, Melo-Pinto P, Raimondo S, Geuna S, Giacobini-Robecchi MG (2004) Functional and morphological assessment of a standardized rat sciatic nerve crush injury with a non-serrated clamp. J Neurotrauma 21:1652–1670
Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, Takamatsu I, Saruta T (2004) Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2. Circ Res 95:e45–e55
Wang L, Yuan D, Zhang D, Zhang W, Liu C, Cheng H, Song Y, Tan Q (2015) Ginsenoside re promotes nerve regeneration by facilitating the proliferation, differentiation and migration of Schwann cells via the ERK- and JNK-dependent pathway in rat model of sciatic nerve crush injury. Cell Mol Neurobiol 35:827–840
Welin D, Novikova LN, Wiberg M, Kellerth JO, Novikov LN (2009) Effects of N-acetyl-cysteine on the survival and regeneration of sural sensory neurons in adult rats. Brain Res 1287:58–66
Wilson AD, Hart A, Brannstrom T, Wiberg M, Terenghi G (2003) Primary sensory neuronal rescue with systemic acetyl-L-carnitine following peripheral axotomy. A dose-response analysis. Br J Plast Surg 56:732–739
Wilson AD, Hart A, Brannstrom T, Wiberg M, Terenghi G (2007) Delayed acetyl-L-carnitine administration and its effect on sensory neuronal rescue after peripheral nerve injury. J Plast Reconstr Aesthet Surg 60:114–118
Wilson AD, Hart A, Wiberg M, Terenghi G (2010) Acetyl-l-carnitine increases nerve regeneration and target organ reinnervation – a morphological study. J Plast Reconstr Aesthet Surg 63:1186–1195
Wood MD, Mackinnon SE (2015) Pathways regulating modality-specific axonal regeneration in peripheral nerve. Exp Neurol 265:171–175
Xiao WD, Yu AX, Liu DL (2014) Fasudil hydrochloride could promote axonal growth through inhibiting the activity of ROCK. Int J Clin Exp Pathol 7:5564–5568
Yan CY, Greene LA (1998) Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway. J Neurosci 18:4042–4049
Yan Y, Sun HH, Hunter DA, Mackinnon SE, Johnson PJ (2012) Efficacy of short-term FK506 administration on accelerating nerve regeneration. Neurorehabil Neural Repair 26:570–580
Yang WW, Pierstorff E (2012) Reservoir-based polymer drug delivery systems. J Lab Autom 17:50–58
Yin ZS, Zhang H, Bo W, Gao W (2010) Erythropoietin promotes functional recovery and enhances nerve regeneration after peripheral nerve injury in rats. AJNR Am J Neuroradiol 31:509–515
Yuan H, Zhang J, Liu H, Li Z (2013) The protective effects of resveratrol on Schwann cells with toxicity induced by ethanol in vitro. Neurochem Int 63:146–153
Zanon RG, Cartarozzi LP, Victorio SC, Moraes JC, Morari J, Velloso LA, Oliveira AL (2010) Interferon (IFN) beta treatment induces major histocompatibility complex (MHC) class I expression in the spinal cord and enhances axonal growth and motor function recovery following sciatic nerve crush in mice. Neuropathol Appl Neurobiol 36:515–534
Zhang CG, Welin D, Novikov L, Kellerth JO, Wiberg M, Hart AM (2005) Motorneuron protection by N-acetyl-cysteine after ventral root avulsion and ventral rhizotomy. Br J Plast Surg 58:765–773
Zuo J, Neubauer D, Graham J, Krekoski CA, Ferguson TA, Muir D (2002) Regeneration of axons after nerve transection repair is enhanced by degradation of chondroitin sulfate proteoglycan. Exp Neurol 176:221–228
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Rayner, M.L.D., Healy, J., Phillips, J.B. (2020). Drug Therapies for Peripheral Nerve Injuries. In: Phillips, J., Hercher, D., Hausner, T. (eds) Peripheral Nerve Tissue Engineering and Regeneration. Reference Series in Biomedical Engineering(). Springer, Cham. https://doi.org/10.1007/978-3-030-06217-0_16-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-06217-0_16-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-06217-0
Online ISBN: 978-3-030-06217-0
eBook Packages: Springer Reference EngineeringReference Module Computer Science and Engineering